Funded Tech Companies
Autobahn Therapeutics
Autobahn Therapeutics is a leading biopharmaceutical company, based in San Diego. Venture capital investment came from Pfizer Venture Investments, Biogen Idec and Alexandria Venture Investments.
Company Overview
Company Name
Autobahn Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
9880 Campus Point Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/10/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Finney
Chief Scientific Officer
Brian Stearns
President
Keith Lenden
Vice President
Chan Beals
Vice President
Deidre MacKenna
VP - Administration
John Borkholder
VP - Operations
Christine Maurer
Company Investors
- Pfizer Venture Investments
- Biogen Idec
- Alexandria Venture Investments
- Bristol-Myers Squibb
- Invus
- BVF Partners
- Cowen Capital Partners (Timothy Anderson)
- Section 32
- Arch Venture Partners (Kristina Burow)
- Samsara BioCapital
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs